A Study of Enfortumab Vedotin in People With Urothelial Carcinoma of the Upper Urinary Tract

Summary

The purpose of this study is to find out whether the study drug, enfortumab vedotin, is an effective and safe treatment for people who have urothelial carcinoma of the upper urinary tract. Study participants will be people who are not eligible to receive or have chosen not to receive the chemotherapy drug cisplatin for treatment of their cancer. In addition, all participants will be planning on having standard surgery to remove their tumor.

Timeline

Start

2023-06-02

Primary completion

2027-06-02

Completion

2027-06-02

Drugs

Indications